Advertisement

Topics

Osteologix Company Profile

03:16 EDT 25th September 2018 | BioPortfolio

Osteologix was formed early in 2003 as Nordic Bone A/S based on venture capital funding from the Scandinavian venture fund Nordic Biotech K/S and proprietary rights associated with the company’s primary development project.At the company’s inception, Dr. Klaus Eldrup Jørgensen assumed the role of CEO. In November 2003 Dr. Stephan Christgau joined the company as COO and acting CEO while Klaus Eldrup Jørgensen assumed the role of Executive chairman of the board. The company has aggressively pursued the development of its lead candidate drug for osteoporosis as well as other attractive secondary indications. In doing so, the company has been assisted by leading experts within the fields of clinical development and registration of pharmaceutical products for bone related diseases, serving as consultants and clinical advisors to the company. Nordic Bone has maintained a strong focus on developing its intellectual property rights (IPR) portfolio and has filed more than 25 patent applications.
In October 2004, Chuck Casamento joined the company as CEO, concomitant with the renaming of the company to Osteologix and the establishment of a US subsidiary. This marked a hallmark in the development of the company which is now set to successfully establish and grow its business as a major pharmaceutical drug development player in the metabolic bone and cartilage disease areas.

Location

425 Market Street, Suite 2230
San Francisco
California
94105
United States of America

Contact

Phone: 415-955-2700
Fax: 415-955-2727
Email: info@ osteologix.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Osteologix Inc.

Osteologix develops proprietary therapeutics for the treatment of unmet medical needs in bone disease and women's health. The Company's lead product, NB S101, is being evaluated i...

Osteologix, Inc.

Osteologix is a specialty pharmaceutical company committed to developing innovative therapies for the treatment and prevention of diseases of bone and joint tissues. Its lead prod...

Osteologix

Osteologix was formed early in 2003 as Nordic Bone A/S based on venture capital funding from the Scandinavian venture fund Nordic Biotech K/S and proprietary rights associated with the company’s pri...

More Information about "Osteologix" on BioPortfolio

We have published hundreds of Osteologix news stories on BioPortfolio along with dozens of Osteologix Clinical Trials and PubMed Articles about Osteologix for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Osteologix Companies in our database. You can also find out about relevant Osteologix Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record